Stay updated on BrigHTN Study of CIN-107 in Treatment-Resistant Hypertension Clinical Trial
Sign up to get notified when there's something new on the BrigHTN Study of CIN-107 in Treatment-Resistant Hypertension Clinical Trial page.

Latest updates to the BrigHTN Study of CIN-107 in Treatment-Resistant Hypertension Clinical Trial page
- Check7 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2. The study page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedA site-wide NIH notice appears above the page, announcing the transition from “Artificial Intelligence” to “Super Intelligence” terminology and linking to updates and FAQs.SummaryDifference1%

- Check21 days agoChange DetectedThe footer’s site revision changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check49 days agoChange DetectedA 403 Forbidden error page is now shown instead of the study details, indicating the page is inaccessible. This affects the user experience by preventing access to the study record content.SummaryDifference17%

- Check70 days agoChange DetectedThe page's revision label was bumped from v3.6.5 to v3.6.6, indicating a minor maintenance update to the page.SummaryDifference0.0%

Stay in the know with updates to BrigHTN Study of CIN-107 in Treatment-Resistant Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BrigHTN Study of CIN-107 in Treatment-Resistant Hypertension Clinical Trial page.